Adaptive Biotechnologies Corp. (ADPT)
28.35
+0.98
(+3.58%)
USD |
NASDAQ |
Oct 02, 16:00
28.34
-0.02
(-0.05%)
Pre-Market: 20:00
Adaptive Biotechnologies Net Income (Quarterly) : -39.94M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -39.94M |
| March 31, 2026 | -20.02M |
| December 31, 2025 | -13.58M |
| September 30, 2025 | 9.545M |
| June 30, 2025 | -25.59M |
| March 31, 2025 | -29.83M |
| December 31, 2024 | -33.72M |
| September 30, 2024 | -32.10M |
| June 30, 2024 | -46.25M |
| March 31, 2024 | -47.53M |
| December 31, 2023 | -69.47M |
| September 30, 2023 | -50.33M |
| June 30, 2023 | -47.81M |
| March 31, 2023 | -57.70M |
| December 31, 2022 | -40.17M |
| September 30, 2022 | -45.32M |
| Date | Value |
|---|---|
| June 30, 2022 | -52.08M |
| March 31, 2022 | -62.80M |
| December 31, 2021 | -61.36M |
| September 30, 2021 | -56.00M |
| June 30, 2021 | -49.30M |
| March 31, 2021 | -40.64M |
| December 31, 2020 | -44.57M |
| September 30, 2020 | -36.72M |
| June 30, 2020 | -33.54M |
| March 31, 2020 | -31.40M |
| December 31, 2019 | -20.61M |
| September 30, 2019 | -13.95M |
| June 30, 2019 | -16.37M |
| March 31, 2019 | -18.64M |
| June 30, 2018 | -12.50M |
| March 31, 2018 | -12.39M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Personalis, Inc. | -31.68M |
| 10X Genomics, Inc. | -17.93M |
| Alamar Biosciences, Inc. (California) | -13.20M |
| Champions Oncology, Inc. | -0.426M |
| Medpace Holdings, Inc. | 121.36M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 71.55M |
| Total Expenses (Quarterly) | 111.34M |
| EPS Diluted (Quarterly) | -0.2489 |
| Enterprise Value | 4.583B |
| Gross Profit Margin (Quarterly) | 70.15% |
| Profit Margin (Quarterly) | -55.82% |
| Earnings Yield | -1.44% |
| Normalized Earnings Yield | -1.055 |